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ABSTRACT. Sleep disordered breathing (SDB), 
i.e., obstructive, central or mixed sleep apneas, 
has been recognized as a common occurrence in 
the elderly. Aging is per se associated with a de-
crease in the quality of sleep; SDB may further 
disrupt the sleep architecture in older subjects. 
The prevalence of obstructive sleep apnea (OSA) 
increases with aging; available studies report prev-
alence rates of 11-62%. Furthermore, OSA has 
been associated with increased mortality in older 
adults. Central apneas and periodic breathing oc-
cur with increased frequency either in subjects 
with neurological disorders such as infarction, tu-
mor, sequelae of infection, diffuse encephalopa-
thies, or in chronic heart failure. Patients with 
cerebrovascular disease (stroke, or transient 
ischemic attacks) have a markedly high prevalence 
of SDB, mainly OSA. In these patients, SDB is 
associated with a poorer functional prognosis at 3 
and 12 months after the acute event, and a higher 
mortality. The clinical impact of SDB on cognitive 
function appears to be modest in patients without 
dementia, although there is a moderate increase 
in daytime sleepiness. In Alzheimer’s disease (AD) 
however, SDB occurs more frequently than in non-
demented older subjects, and its severity is corre-
lated with the degree of cognitive impairment. The 
hypothesis of a causal relationship between AD 
and SDB remains a subject of controversy. The 
possibility of SDB should be considered in the 
elderly in the differential diagnosis of “reversible 
dementias”, increased daytime sleepiness, or un-
explained right-sided heart failure.  
(Aging Clin. Exp. Res. 12: 417-429, 2000)
©2000, Editrice Kurtis
INTRODUCTION
In 1996, 14.2% of the Swiss population was over 
65 years of age; according to WHO estimates, this 
proportion is expected to reach 20% by the year 
2020 (1). Aging is associated with an increasing 
frequency of dissatisfaction with the quality of sleep; 
indeed, one half of subjects aged over 65 and living 
at home, and two thirds of those residing in long-
term facilities suffer from sleep disorders (2). 
The etiological diagnosis of sleep disorders may be 
difficult in the elderly; somatic disorders such as heart 
disease, stroke, Parkinson’s disease, chronic pain, 
chronic pulmonary diseases, nocturnal polyuria, and 
psychiatric diseases such as depression and dementia 
– which are more prevalent in the elderly – may all 
have a negative impact on the quality of sleep. Fur-
thermore, “normal” aging appears to be associated 
with changes in the quality of sleep such as decreased 
slow-wave sleep, increased fragmentation of sleep, 
more frequent arousals and night-time wakefulness 
(3).
Among the secondary causes of sleep disruption, 
“sleep disordered breathing” (SDB) has been increas-
ingly recognized as a common occurrence in the 
elderly (4-6). The concept of SDB encompasses dis-
turbances of the breathing pattern occurring only or 
primarily during sleep such as obstructive sleep ap-
nea or hypopnea, central or mixed apnea syndromes, 
periodic breathing and nocturnal hypoventilation (7). 
Although a significant proportion of elderly subjects 
have SDB, controversy exists regarding its clinical 
significance in older subjects, i.e., its relationship to 
cognitive impairment and to increased morbidity or 
mortality (8). The diagnosis of SDB is often delayed 
in elderly subjects because of: 1) atypical clinical 
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presentations; 2) the frequency of sleep-related com-
plaints in this age group considered – by the patient 
and the physician – as inherent to normal aging; and 
3) the difficulty in performing polygraphic or polys-
omnographic recordings in older patients with cogni-
tive impairment. 
This review describes the age-associated physio-
logical changes in sleep architecture and breathing 
during sleep, and analyzes the clinical relevance of 
SDB, and its occurrence in frequent medical condi-
tions associated with aging such as congestive heart 
failure, cerebrovascular disease, and dementia. We 
will not discuss the modifications in breathing pat-
tern associated with chronic lung disorders, or obes-
ity (i.e., nocturnal alveolar hypoventilation), as well 
as other causes of sleep disruption such as periodic 
leg movements.
PHYSIOLOGICAL CHANGES IN 
BREATHING DURING SLEEP
Sleep architecture
Two distinctive electroencephalographic (EEG) 
sleep states have been defined: rapid eye movement 
sleep or paradoxical sleep (REM), and non-rapid eye 
movement sleep (NREM). NREM sleep is subdivided 
into four stages of progressively deepening sleep (I-
IV). Normal sleep comprises a recurring pattern of 
sequential stages (NREM, then REM sleep) with a 
periodicity of 60-100 minutes; the 2 or 3 first cycles 
encompass NREM stages III and IV, the last cycles 
are of shorter duration, and do not usually comprise 
slow- wave sleep.
Breathing and ventilatory control during sleep
Sleep onset is associated with a reduction in re-
ticular activating system (RAS) activity, which is 
thought to be responsible for the fall in respiratory 
drive noted during sleep (9). During stages I and II 
(about 60% of total sleeping time), total ventilation 
(VE) decreases slightly: this change is a consequence 
of a fall in tidal volume (Vt), but breathing frequen-
cy (FR) remains unchanged; periodic breathing 
(gradual waxing and waning of Vt over 30-60 sec-
ond cycles) occurs physiologically during NREM 
stages I and II, with central apneas lasting less than 
15 seconds, and increases in frequency with aging. 
During stages III and IV (approximately 20% of 
total sleeping time), also referred to as slow-wave 
sleep because of the characteristic EEG pattern, VE 
further declines (-15% compared to wakefulness), 
mainly through a decrease also in Vt; this causes a 
physiological increase in arterial partial pressure of 
carbon dioxide (PaCO2) of 3-7 mmHg (0.4-0.9 
kPa), and a decrease in arterial partial pressure of 
oxygen (PaO2) of 3.5 to 9.4 mmHg (0.5-1.3 kPa), 
i.e., an approximate 2% fall in oxygen saturation 
(SaO2); the pattern of breathing is regular, apneas 
are rare (2). 
With the onset of NREM sleep, upper airway re-
sistance approximately doubles because of a decrease 
in peripheral muscular tone, and a loss of EMG activ-
ity affecting dilator muscles of the upper airways. 
During REM sleep (20% of total sleeping time), 
the pattern of breathing is irregular, with variations 
in both Vt and FR; paradoxical chest movements may 
be noted; central apneas lasting less than 15 seconds 
are frequent. Peripheral muscle tone is abolished; this 
is also the case with the muscles that control upper 
airway patency, thus increasing the likelihood of up-
per airway obstruction during REM sleep (9). VE is 
decreased as in slow-wave sleep.
AGE-RELATED CHANGES IN SLEEP 
ARCHITECTURE, BREATHING AND 
VENTILATORY CONTROL
Sleep architecture
Objective studies of sleep architecture demonstrate 
increased sleep fragmentation, and decreased sleep 
quality in the elderly (Fig. 1). Characteristic age-asso-
ciated EEG changes (2, 10) such as a decrease in the 
amplitude of slow waves (stages III and IV, restorative 
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Figure 1 - Changes in sleep architecture associated with aging: 
decrease in NREM stages III and IV, increased sleep fragmenta-
tion and number of arousals. Adapted from: Kales A., Kales J., 
N. Engl. J. Med. 290: 487-499, 1974.
component of sleep), a reduction in the total amount 
of slow-wave sleep, and an increase in the number of 
changes in sleep stages, are summarized in Table 1. 
These changes appear to be related to age-related 
neuronal loss, and disturbances of circadian oscilla-
tors (2). Aging is also associated with a reduction in 
sleep efficiency (i.e., the ratio of time spent in bed to 
time spent asleep), and an increased frequency of 
daytime napping.
Breathing and ventilatory control
Aging is associated with a marked attenuation in 
the heart rate and ventilatory responses to hypoxia 
and hypercapnia (11-13). Indeed, Kronenberg et al. 
compared the responses to hypercapnia and hy-
poxia of healthy young men (aged 22-30) to those 
of older men (aged 64-73); in the older group, the 
ventilatory response to hypercapnia was decreased 
by 60%, and the response to hypoxia by 75%, com-
pared to the younger subjects. These observations 
suggest that there is an age-related decline in the 
ability to integrate information received from sen-
sors (peripheral and central chemoreceptors, 
mecanoreceptors), and generate appropriate neural 
activity. 
The hypoxic ventilatory response is reduced dur-
ing sleep; it decreases more during NREM sleep, 
than during REM sleep (2). Noteworthy is the fact 
that sleep deprivation further diminishes the noctur-
nal ventilatory responses to hypoxia and hypercapnia 
(14). Arousal from sleep is preserved during hyper-
capnia, but markedly impaired during hypoxia. This 
impaired ventilatory response may prolong the dura-
tion of apneas or hypopneas, and result in more se-
vere oxygen desaturations in elderly subjects, espe-
cially during REM sleep. 
Aging is also associated with a diminished percep-
tion of added resistive loads, such as that generated 
by upper airway collapse (15-17). Furthermore, 
when compared to younger adults, older subjects 
generate a decreased inspiratory effort during ob-
structive sleep apnea (18).
OBSTRUCTIVE SLEEP APNEA SYNDROME 
(OSA)
Pathophysiology and clinical consequences
OSA refers to repetitive episodes of upper airway 
obstruction occurring during sleep. Cessation of air-
flow for at least 10 seconds (apnea) or a 50% reduc-
tion in airflow for at least 10 seconds (hypopnea) 
occur despite continuing respiratory effort (i.e., per-
sistent thoracic and/or abdominal movements on 
polysomnographic recordings) (Fig. 2). Upper airway 
obstruction is a consequence of the hypotonic mus-
cular tone of the dilator muscles of the pharynx 
which increases the collapsibility of the upper airway, 
and the negative airway pressure generated by the 
inspiratory muscles. The gravitational effects of the 
supine posture usually adopted for sleep tend to fur-
ther promote the upper airway obstruction (posterior 
movement of the tongue). Apneas cause blood oxy-
gen desaturation. Repeated arousals occur because 
of increasing respiratory effort (14, 19), and to a 
lesser degree, hypoxia, leading to increased fragmen-
tation of sleep (20). 
The principal symptoms of OSA (daytime sleepi-
ness, and slight to moderate neuropsychological im-
pairment) result from the repeated arousals required 
to re-establish sufficient muscular tone in the pharynx 
to reopen the upper airways, and the decrease in 
stages 3 and 4 and in REM sleep (21). 
Snoring, obesity and male sex are major risk fac-
tors for OSA (3, 22). Upper airway morphology 
(pharyngeal cross-section, size of the mandible) is 
also a major contributive factor (23, 24). The recur-
rent hypoxemic episodes that characterize OSA, 
particularly if associated with COPD and/or daytime 
hypoxemia, may lead to both pulmonary and sys-
temic hypertension, cardiac arrhythmias, and possi-
bly decreased survival (25).
Epidemiology
The wide variability in the reported prevalence of 
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Table 1 - Age-related changes in sleep architecture.
Time in bed (TIB) Increased
Total sleep time (TST) Unchanged if nap included
Sleep efficiency (TST/TIB) Decreased
Sleep fragmentation Increased
NREM Stage I Small increase
NREM Stage II Increased due to decrease in slow-wave sleep
NREM Stages III and IV Decreased
REM sleep  No change in % of TST
Adapted from Burger et al. (2).
OSA results from the use of different criteria for de-
fining and quantifying respiratory events. Indeed, 
different thresholds for normal vs pathological sleep 
have been used in prevalence studies: an apnea index 
(AI) of 5-15/h, or an apnea-hypopnea index (AHI) of 
5-20/h (also labelled RDI: respiratory disturbance 
index) (26).
In younger adult populations (i.e., aged under 60), 
the prevalence of OSA (AHI>15/h) is currently esti-
mated to be 4% in women and 9% in men (27). The 
prevalence increases in post-menopausal vs pre-
menopausal women.
A large prevalence study based on a questionnaire 
survey of 1389 subjects aged 65±3 years reported 
that 49.5% of participating subjects were snorers, 
and 10.8% suffered from nocturnal apneic episodes 
(28). However, few prevalence studies, based on ei-
ther polysomnography or polygraphy, include more 
than 50 subjects. Hoch et al. (Table 2A) studied 105 
healthy elderly subjects aged 60-91 years by polys-
omnography: 13.3% had an AHIr10/h, and 6.8% 
had an AIr10; the median AHI increased signifi-
cantly across decades from age 60 to age 90 years, 
and the prevalence of SDB clearly increased with 
aging; 69% of all events were central apneas, 22% 
were obstructive apneas; 8% were mixed events (6). 
The largest prevalence studies were published by 
Ancoli-Israël et al. (4). Her largest study includes 
data from a random sample of 427 elderly commu-
nity-dwelling persons in the San Diego area (Table 
2B) studied by polygraphy (thoracic and abdominal 
Respitrace® bands, peripheral EMG, and wrist activ-
ity); in this study, the prevalence of an AIr5 was 
24%, and that of an AHIr10 was 62%. In subjects 
with an AIr5, 59% of all respiratory events were 
obstructive apneas, 30% were central apneas, and 
10% were mixed apneas. Ancoli-Israël et al. also 
studied 200 patients from a nursing home (mean 
age: 81.9±8.6); 41% of all patients had an AIr5/h, 
and 11% had an AIr10/h (percentage of obstructive 
apneas not specified) (29). Another study by Hoch 
et al. including 56 healthy elderly individuals aged 
69±5 years found lower prevalence rates; 5.3% had 
an AIr5, and 3.6% an AIr10, all respiratory events 
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Table 2A - Prevalence of sleep disordered breathing per age group.
Age 60-69 70-79 80-89 All
No. 34 33 38 105
Age (mean±SD) 65.1 (2.7) 73.0 (2.9) 83.5 (3.0) NA
No. of subjects (%):
AHIr5     1 (2.9)      11 (33.3)      15 (39.5)     27 (25.7)
AHIr10     1 (2.9)         5 (15.1)        8 (21.1)     14 (13.3)
AIr5  0 (0)        4 (12.1)        7 (18.9)     11 (10.7)
AIr10  0 (0)      2 (6.1)        5 (13.5)     7 (6.8)
Data from Hoch C.C. et al. (6). NA: not available; AI: apnea index; AHI: apnea-hypopnea index.
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Figure 2 - Polysomnographic recording in a 66-year-old male subject; only airflow, chest movements and abdominal movements are 
shown. Upper tracing shows airflow (and airflow cessation: apneas); “chest effort” and “abdominal effort” tracings show persistent 
respiratory efforts during apneas. The segment shown represents 5 minutes of recording.
being equally divided between central, obstructive 
and mixed apneas (30).
Noteworthy is the frequent occurrence of OSA in 
patients with chronic obstructive pulmonary disease 
(COPD). Indeed, COPD is highly prevalent in elderly 
patients, and OSA occurs in 10 to 15% of COPD 
patients (31). The coexistence of OSA and COPD 
defines the “overlap syndrome”. Patients with the 
“overlap syndrome” tend to have a lower baseline 
SaO2 and a higher PaCO2 than patients with OSA 
alone; they are also at higher risk of developing epi-
sodes of profound hypoxemia during sleep than non-
COPD patients; they are therefore particularly prone 
to suffer from the complications of chronic hypox-
emia such as cor pulmonale, pulmonary hyperten-
sion, and polycythemia (31, 32).
In summary, snoring, a known risk factor for 
OSA, is highly prevalent in subjects aged >65; the 
prevalence of pathological AI and AHI increases 
significantly with aging, 30 to 60% of the respiratory 
events being obstructive apneas. The possibility of an 
“overlap syndrome” should be considered in elderly 
COPD patients with an increased body-mass index 
(32).
Mortality and OSA in the elderly
Several publications have shown that OSA is as-
sociated with an increased risk for mortality (33). In 
a cohort study of 198 non-institutionalized elderly 
individuals aged 67±8 years, Bliwise et al. showed 
that an AHI>10/h was associated with an increased 
hazard of cardiovascular death (34). In 233 elderly 
subjects living in nursing homes, Ancoli-Israël et al. 
also noted that patients with OSA had a greater ten-
dency to die in their sleep, and that there was a 
strong association between AHI and mortality in 
women (35). 
The impact of OSA on neuropsychological func-
tion will be discussed under the subheading “SDB 
and cognitive impairment”.
Treatment of OSA in the elderly
Treatment of OSA includes modification of behav-
ioral factors (such as weight loss, avoidance of alco-
hol, smoking, and sedative or hypnotic drugs), nasal 
continuous positive pressure (nCPAP), mandibular 
advancement devices, and surgical procedures.
Weight loss, in obese patients with OSA, may 
significantly decrease the number of apneic events, 
and sleep disruption, and increase nocturnal SaO2. 
Thyroid replacement therapy is mandatory in 
patients with hypothyroidism, which should be sought 
for in all documented cases of SDB.
Use of hypnotics and psychotropic agents should 
be discouraged in patients with OSA, because of the 
risk of increasing the frequency and length of apneas 
and hypopneas. Protriptyline is the only psycho-
tropic agent which has a minor impact on OSA; 
protriptyline decreases REM-associated OSA, but has 
no documented effect on OSA occurring during 
NREM sleep; in selected patients with mainly REM-
associated OSA, protriptyline may improve sleep 
oxygenation, and decrease sleepiness (36).
Continuous Positive Airway Pressure via a nasal 
mask (nCPAP), the most widely used treatment for 
OSA, has been shown to improve nocturnal oxygen 
saturation, quality of sleep, and quality of life, in 
younger adults. To date, there are no studies of the 
use and impact of long-term nCPAP in elderly sub-
jects. Interestingly however, nCPAP is widely used in 
older subjects; in Switzerland, 14% of all nasal CPAP 
devices were used by patients aged over 65 years 
(37); in France, approximately 20% of the 13900 
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Table 2B - Prevalence of sleep disordered breathing per age group.
     All
No. of subjects 166   201 53  420
Age (mean±SD)    72.4 (6.4)
Age groups: range 65-69   70-79 80-89  65-99
No. of subjects (%) with:
  AIr5 43 (26)   43 (21) 14 (26) 100 (24)
  AIr10 20 (12) 13 (6) 10 (19)  43 (11)
  AIr20 6 (4)   6 (3) 4 (8) 16 (4)
No. of subjects 152   181 52  385
Age groups: range 65-69   70-79 80-89  65-99
No. of subjects (%) with:
  AHIr10 93 (61) 113 (62) 34 (65) 240 (62)
  AHIr20 66 (43)   77 (43) 27 (52) 170 (44)
  AHIr40 37 (24)   38 (21) 17 (33)  92 (24)
Data from S. Ancoli-Israël et al. (4).
subjects under home nCPAP therapy in 1996 and 
followed by ANTADIR (National association for the 
domiciliary treatment of patients with respiratory 
insufficiency) were aged 70 and over (Fig. 3). Long-
term acceptance of positive pressure ventilation via 
nasal mask has been documented in patients aged 75 
and over, suggesting that its use is feasible in this age 
group, although the issue of nCPAP in the elderly 
has not been specifically addressed (38). Acceptance 
of nCPAP is, however, low in patients who suffer 
from few OSA-related symptoms, or who suffer from 
cognitive impairment, both being frequent occur-
rences in the elderly. 
Patients with the “overlap syndrome” and daytime 
PaO2 above 60 mmHg should be treated as patients 
with OSA, i.e., with nocturnal nCPAP or, in patients 
with associated hypoventilation and hypercapnia, 
non-invasive positive pressure ventilation (NIPPV). 
Nocturnal oxygen therapy alone in patients with an 
“overlap syndrome” carries the risk of increasing 
nocturnal PaCO2, and has not been shown to im-
prove OSA-associated daytime symptoms, quality of 
sleep or prognosis (39).
Mandibular advancement devices are considered 
as second-line therapy, for patients who do not toler-
ate nCPAP. Many different devices are available, but 
one major limitation is that appliances need to be 
fixed on the patients teeth, and cannot be used in 
patients with dentures (19).
Several surgical procedures are available for the 
treatment of OSA: surgical or laser-assisted uvu-
lopalatopharyngoplasty (UPPP); inferior mandibular 
osteotomy and genioglossal advancement with hyoid 
myotomy and suspension (MOHM), or maxillo-man-
dibular advancement osteotomy (MMO) (40, 41). 
However, available data concerning either UPPP, 
MOHM, or MMO refer essentially to patients in the 
40 to 55 years of age group (41). Surgical options 
are rarely considered in elderly subjects for several 
reasons: 1) The frequent occurrence of comorbidities 
in older subjects increases the risk of surgical proce-
dures and general anesthesia. 2) The impact of UPPP 
or MOHM is unknown in older patients, and modest 
in younger adults; indeed, the success rate of UPPP 
[defined as a post-operative decrease in the respira-
tory disturbance index (sum of AI and AHI) of at least 
50% and a post-operative value below 20/h] is 52% 
in carefully selected patients, and drops to less than 
20% in patients with combined retropalatal and 
retrolingual obstruction, or retrolingual obstruction 
alone (41). MOHM has a success rate of up to 60% 
when performed by experienced surgeons in special-
ized centers in younger adults; no data are available, 
however, for the old and very old. 3) Advanced age 
per se is considered as a contra-indication for MMO 
in a comprehensive review on surgical management 
of OSA by Powell et al. (40).
CENTRAL APNEA
Central apnea (CA) episodes are associated with 
complete cessation of respiratory effort. It has been 
suggested that CA occurs at 4 to 10% of the rate of 
OSA (42). Patients with CA can be subdivided into 2 
groups: those with a depressed central drive, and 
those with a normal or increased respiratory (or 
chemical) drive. 
The first group comprises subjects with lesions to 
the brainstem such as sequelae of infections, infarc-
tion, and tumor (bilateral posterolateral medullary 
lesions); the clinical syndrome mimics “Ondine’s 
curse”, i.e., failure of automatic respiration with oc-
currence of predominantly nocturnal central hypov-
entilation. This has also been described in encepha-
litis, cervical cordotomy, bulbar poliomyelitis, the 
Shy-Dragger syndrome, multiple sclerosis, and after 
radiation necrosis. A decline in central drive with oc-
currence of CA can also be seen in certain neuromy-
opathies such as amyotrophic lateral sclerosis, myo-
tonic dystrophy, muscular dystrophy, and myasthenia 
gravis (43).
The second group comprises subjects with a pre-
served or increased respiratory (chemical) drive. CA 
occurs physiologically in subjects breathing at high 
altitude, where chronic hyperventilation causes Pa-
CO2 to be low, and drop below the apneic threshold, 
leading to periodic breathing. The same mechanisms 
are implicated in the association between chronic 
heart failure and periodic breathing (Cheyne-Stoke 
respiration).
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Figure 3 - Data from the 1996 ANTADIR observatory; fre-
quency of prescription of home nCPAP per age group 
(N=13900 patients).
In the elderly, CA is most often associated with 
cardiovascular or cerebrovascular diseases; it also 
occurs as a consequence of diffuse encephalopathies, 
or severe metabolic disorders (hepatic or renal fail-
ure). Noteworthy is the interaction between CA and 
obstructive apnea; the majority of patients with CA 
also have obstructive events, i.e., mixed apneas (4, 
6); upper airway collapse may occur at the nadir of 
periodic breathing, when the drive to the inspiratory 
muscles and upper airway muscles is minimal, induc-
ing obstructive apnea. Furthermore, the occurrence 
of obstructive apneas tends to increase the instability 
of the respiratory control system (i.e., prolonged 
apneas, increased compensatory hyperventilation).
SDB AND CONGESTIVE HEART FAILURE 
(CHF): CHEYNE-STOKES BREATHING
Pathophysiology and clinical presentation
Periodic, or Cheyne-Stokes breathing (CSB), oc-
curs in patients with severe heart failure; this abnor-
mal breathing pattern, characterized by alternating 
periods of hyperpnea and hypopnea or apnea, is a 
form of central apnea, and is much more common 
during sleep than wakefulness (Fig. 4). The putative 
mechanism of CSB is related to an increased sensitiv-
ity of the respiratory centers to carbon dioxide (CO2) 
(44-47). As previously noted, during sleep, total VE 
decreases, and PaCO2 rises by 3-7 mmHg. If during 
sleep PaCO2 drops below a certain level, referred to 
as the apneic threshold, ventilation ceases (central 
a p n e a )  a n d 
PaCO2 is restored to its previous level. In persons 
with increased sensitivity to CO2, the negative feed-
back system that controls breathing elicits a large 
ventilatory response when PaCO2 rises (“increased 
controller gain”); by driving PaCO2 below the apneic 
threshold, the consequent hyperventilation results in 
central apnea. This can explain recurring cycles of 
central apnea and hyperventilation during sleep. The 
presence of hypoxemia can further increase the slope 
of the ventilatory response to hypercapnia. Further-
more, patients with CSB have a significantly lower 
diurnal PaCO2 and transcutaneous nocturnal CO2 
(PtcCO2) than subjects without CSB, probably as a 
consequence of interstitial edema, and stimulation of 
pulmonary irritant and juxtacapillary stretch recep-
tors: as such, smaller variations in VE can bring Pa-
CO2 below the apneic threshold, and induce peri-
odic breathing (47). Indeed, the finding of a low diur-
nal PaCO2 in patients with heart failure is highly 
predictive of CSB. The contribution of a prolonged 
circulation time is probably not a key factor in the 
genesis of CSB, although it is important in determin-
ing the length of the cycles in CSB (44, 45).
CSB causes considerable disruption of sleep archi-
tecture, with a markedly increased number of arousals 
and sleep stage changes, and may mimic the clinical 
picture of OSA (Fig. 5) (48). Patients with CSB have 
an increase in stages I and II of NREM sleep, and a 
decrease in slow-wave sleep (47, 48). Many patients 
with CSB present symptoms of disturbed sleep; polys-
omnographic recordings show that apneic episodes are 
frequently followed by arousals, and patients also suffer 
from paroxysmal nocturnal dyspnea, difficulty in initiat-
ing sleep, or insomnia. CSB has also been noted to 
induce acute confusion (delirium) (49).
Figures 4 and 5 show the typical ventilatory pat-
tern of CSB during polysomnography in a patient 
with chronic left ventricular dysfunction (cardiomy-
opathy), and the alterations in sleep architecture as-
sociated with CSB.
Treatment of CSB
Treatment is based on optimal management of 
CHF, the use of theophylline and acetazolamide (as 
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Figure 4 - Polysomnographic recording in a 71-year-old male subject, suffering from severe cardiomyopathy; only airflow, chest 
movements and abdominal movements are shown. Airflow tracing shows Cheyne-Stokes breathing; “chest effort” and “abdominal 
effort” tracings show disappearance of respiratory efforts during apneas (central apneas).
stimulants for the respiratory centers) (36), nasal 
nCPAP (at pressures of +5 to +10 cm H2O, to de-
crease ventricular afterload by decreasing transmural 
ventricular pressure), and rarely, nocturnal respira-
tory assistance with bi-level positive airway pressure 
(BiPAP) (47). A bi-level barometric ventilator specifi-
cally designed for the treatment of CSB has been 
recently commercialized, and is undergoing clinical 
evaluation (ResMed Autoset CS®). Figure 6 shows 
the effect of nCPAP on transmural ventricular pres-
sure for a given systolic blood pressure, explaining 
the positive effect of nCPAP on afterload of the left 
ventricule. 
SDB AND CEREBROVASCULAR DISEASE
Recent studies suggest a high prevalence of SDB 
(predominantly OSA) associated with either transient 
ischemic attacks (TIA), or stroke (50-53). Bassetti et al. 
studied by polysomnography 39 subjects (mean age: 
57 years) within 10 days of a first episode of acute 
stroke; OSA with an AHI>10 was found in 14 subjects 
(36%), Cheynes-Stokes in 4 (10%), and mixed SDB in 
7 (18%). Prevalence of SDB was similar in those with 
supratentorial and infratentorial stroke (52). In another 
controlled study of patients after TIA or stroke, 36 
patients underwent polysomnography within 12 days 
after the acute event; 25 subjects (69%) had an 
AHIr10, with a similar proportion in patients with TIA 
or stroke (51). In a study of 47 patients with recent 
ischemic stroke, based on overnight pulse oximetry, an 
increase in desaturation index (DI: number of drops in 
SaO2 / h exceeding 4%) was associated with a poorer 
functional status at 3 and 12 months after the acute 
event, and with a higher 1-year mortality; polysomnog-
raphy of a subgroup of 19 patients suggested that SDB 
was mainly caused by OSA (50).
In summary, patients having suffered from either 
TIA or a recent stroke have a high incidence of 
SDB, mainly caused by OSA; SDB is associated with 
a worse prognosis in these patients. The causal re-
lationship between OSA and cerebrovascular disease 
(CVD) is not settled to date; the increased prevalence 
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Figure 6 - Use of nCPAP in Cheyne-Stokes breathing associated 
with left ventricular failure. Upper Figure shows negative intra-
pleural pressure (Ppl) without nCPAP; transmural ventricular 
pressure, for a systolic blood pressure (SBP) of 120 mmHg, is 
120 -(-3) = 123 mmHg. Lower Figure shows the effect of 8 
mmHg of nCPAP; intrapleural pressure (Ppl) is now +5.0 mm-
Hg; transmural ventricular pressure, for the same SBP, is 120 
- 5 = 115 mmHg, which illustrates the decreased afterload for 
the left ventricle as a consequence of nCPAP. SPLV: systolic 
pressure in left ventricle. Adapted from Escourrou et al. (45).
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Figure 5 - Polysomnographic recording in a 71-year-old male subject, suffering from severe cardiomyopathy. Hypnogram shows 
severe disruption of sleep architecture because of Cheyne-Stokes breathing, with multiple arousals and disappearance of NREM 
stages III and IV. The Figure shown covers recording over one night.
of OSA in patients with CVD may be a cause or a 
consequence of the acute cerebral events. Unfortu-
nately, treatment by nCPAP in these patients is fre-
quently poorly tolerated, and to date no study of its 
impact on the outcome of patients with OSA and a 
history of either TIA or a recent stroke is available.
SDB AND COGNITIVE IMPAIRMENT
Chronic hypoxia has been associated with moder-
ate to severe neuropsychological impairment. Grant 
et al. (54) studied 203 patients with COPD aged 
64±8 years from the Nocturnal Oxygen Therapy 
Trial (NOTT), with a mean daytime PaO2 of 51 
mmHg: 77% of these patients were found to have a 
neuropsychologic deficit; in 42%, these deficits were 
moderate to severe in magnitude, a rate triple that of 
a control group of older subjects without COPD; 
higher cognitive functions (abstracting ability, com-
plex perceptual-motor integration) were most se-
verely affected; this had also been noted by Krop et 
al. (55). Findley et al. (56) studied younger subjects 
with OSA, and found that cognitive impairment as-
sociated with OSA was correlated with mean SaO2 
during sleep and awake PaO2. Interestingly, despite 
these findings, the relationship between SDB and 
cognitive function in older subjects is unclear. Knight 
et al. studied 27 subjects aged 76±6 years; 10 had 
sleep apnea (mean AI: 17/h), 17 had no sleep ap-
nea; although there was a modest increase in day-
time sleep tendency, no significant differences be-
tween the 2 groups were found for any of the cogni-
tive tests, and no correlations were noted between 
neuropsychologic performance and sleep parameters 
(57). Phillips et al. studied 92 subjects aged 64±8 
years by polysomno-graphy; no correlations were 
found between either neuropsychological testing, or 
daytime sleepiness, and indices of SDB (8). Similarly, 
Berry et al. performed polysomnography on 28 
healthy elderly subjects aged 70±6 years (mean AHI: 
4.9±7.6, mean DI: 29±42/h), and found no correla-
tion between SDB indices and daytime functioning or 
neuropsychologic testing (58). According to Hoch et 
al., the severity of SDB did not correlate with day-
time sleepiness, medical burden, or severity of de-
pressive symptoms (Hamilton depression scale) 
(59). 
Conversely, Yesavage et al. (60) performed polys-
omnography and neuropsychological tests in 41 
non-demented male subjects aged 69.5±6.5 years, 
and showed that 5 of the 11 tests performed – test-
ing memory and comprehension – were correlated 
with the AHI (mean AHI: 26±30). In a larger study 
of 427 community-dwelling elderly subjects, Ancoli-
Israël et al. also found a correlation between SDB 
indices and nocturnal wandering or confusion, day-
time sleepiness, and depression (4). More recently, 
Gottlieb et al. reported data on 1824 subjects aged 
65±11 years, with a mean AHI of 11±15/h: a sig-
nificant progressive increase in sleepiness (Epworth 
Sleepiness Scale: ESS) was noted with increasing 
AHI; this relationship was not influenced by age or 
gender (61).
In summary, the clinical impact of SDB on cogni-
tive function and neuropsychologic testing appears 
to be modest in elderly patients without dementia; 
data based on large population studies, however, 
show an increase in daytime sleepiness with increas-
ing SDB indices in older adults.
SLEEP DISORDERS AND ALZHEIMER’S 
DISEASE
The prevalence of dementia is about 1% at the 
age of 60 years, and doubles every five years, to 
reach 30 to 50% by the age of 85. Alzheimer’s dis-
ease (AD) accounts for approximately 70% of all 
cases of dementia (62). Several authors have noted a 
higher prevalence of SDB in patients with AD when 
compared to control groups. Furthermore, anecdotal 
early reports of dementia-like symptoms (memory 
impairment, concentration difficulties, confusion) as-
sociated with sleep apnea (63) led to the speculation 
that there could be a causal relationship between 
SDB and AD: in AD, sleep apnea could be a conse-
quence of cell loss in the brainstem respiratory cent-
ers; conversely, neuronal degeneration in AD could 
be hastened by the nightly insult of intermittent cer-
ebral hypoxemia related to SDB. 
Specific changes in sleep architecture have been 
described in AD: a reduced sleep efficiency, an in-
creased proportion of stage I, a decreased proportion 
of slow-wave sleep and REM sleep, and an increased 
number of awakenings (64). 
Hoch et al. compared the prevalence of SDB in 
patients with AD (N=34) vs three groups: healthy 
controls (N=56); patients with depression (N=35); 
and patients with dementia and depression (N=24). 
A significantly greater proportion of patients with 
AD had an AIr10/h (29%) when compared to con-
trols (3.6%), or patients with depression (8%); the 
predominant type of apnea was obstructive (30). 
Similar findings were reported by Reynolds et al. 
(65) in a controlled study; 43% of patients with AD 
(N=21, aged 70±8 years) had an AIr5 vs 4.3% of 
controls (N=23, aged 69±6). Ancoli-Israël et al. (66) 
studied 235 elderly institutionalized patients (152 
women aged 83.5±8.5 years, and 83 men aged 
79.7±7.5 years) by polygraphy (thoracic and ab-
dominal Respitrace® bands, peripheral EMG, and 
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wrist activity): 43% of the patients had an AIr5; 
138 patients had dementia based on a Mattis De-
mentia Rating Scale (DRS); the mean AHI was sig-
nificantly higher in patients with severe dementia 
than in patients with mild-to-moderate or no de-
mentia; there were significant correlations between 
AHI and the DRS scores for attention, initiation and 
perseveration, construction, conceptualization and 
memory. Two studies, however, failed to detect any 
significant difference between patients with vs with-
out AD as to mean AHI (67, 68). Interestingly, pa-
tients who desaturated overnight were more likely 
to be confused in the morning, suggesting a possi-
ble interaction between AD and SDB (67). Using a 
static charge-sensitive bed, one study (69) compared 
the prevalence of SDB in patients with multi-infarct 
dementia (MID), AD, and healthy controls: patients 
with MID and AD had a higher mean AHI, and a 
higher prevalence of subjects with an AHIr10 than 
controls; also, the prevalence of subjects with an 
AHIr10 tended to increase with the severity of the 
dementia. Little is known about dementia and apnea 
in the severely ill, because of the difficulty in per-
forming sleep studies in a sleep laboratory in this 
group of patients.
Unfortunately, mean nocturnal SaO2, DI, and 
minimal SaO2 are seldom reported.
In summary, SDB has been more frequently stud-
ied in AD than in MID; available data suggest that 
SDB occurs more frequently, and is more severe in 
patients with AD (or MID) than in elderly controls; 
whether SDB is frequent in AD because both dis-
eases are highly prevalent in this age group or be-
cause there is a causal relation between both diseases 
remains a subject of speculation.
DIAGNOSING SDB IN AN ELDERLY 
POPULATION
The gold standard for the diagnosis of SDB is 
polysomnography (PSG), i.e., the simultaneous re-
cording of EEG, eye movements, electromyography, 
airflow, pulse oximetry, electrocardiogram, and chest 
and abdominal movements by inductance plethys-
mography. However, PSG has several major draw-
backs, such as availability, cost, and the difficulty in 
performing it in even moderately demented patients. 
Furthermore, a considerable night-to-night variability 
has been noted in the elderly, with a clear “first night 
effect” on the pattern of sleep, although changes are 
less significant for SDB indices; the use of low cut-off 
values for the diagnosis of SDB (i.e., AHIr5) may 
change the clinical classification of patients from 
night to night (70, 71).
The simplest diagnostic tool for SDB is nocturnal 
pulse-oximetry (Fig. 7). In selected groups of younger 
adults (snorers, obese patients, or patients with com-
plaints suggestive of OSA), nocturnal pulse-oximetry 
is moderately sensitive and specific (although patients 
with predominantly hypopneas are poorly detected). 
Values of sensitivity (Se) and specificity (Sp) vary 
considerably, however, according to the thresholds 
used to define SDB (72). Chiner et al. reported on 
the variations in Se and Sp according to different 
threshold values for ODI (oxygen desaturation index: 
number of drops in SaO2/h exceeding 4%) in out-
patients with symptoms suggestive of OSA, defining 
SDB as AHIr15: for an ODIr5, Se was 82% and Sp 
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Figure 7 - Pulse-oximetry tracing of a 75-year-old male subject with OSA. Upper tracing shows oxygen saturation (SaO2); lower 
tracing shows heart rate. Characteristic asymmetrical desaturations are shown, with SaO2 fluctuating between 80 and 95%. Record-
ing made with Minolta Pulsox 7 oximeter, room air.
76%; for an ODIr10, Se and Sp were respectively 
71 and 90%; for an ODIr15, Se was 62% and Sp 
93% (73). However, the diagnostic value of nocturnal 
pulse-oximetry in the elderly is unknown: groups at 
high risk for OSA are more difficult to identify in 
older subjects because of the paucity or lack of spe-
cificity of symptoms; specificity will most probably 
drop because of the frequency of CA and CSB in the 
elderly; to date, no study has approached the validity 
of nocturnal pulse-oximetry – or that of algorythms 
combining clinical data and nocturnal pulse-oximetry 
– in the elderly. The same is true for polygraphy; to 
be clinically contributive in older subjects, a poly-
graphic recording must offer the possibility of differ-
entiating CA or CSB from OSA, which requires in-
ductance plethysmography to analyze chest and ab-
dominal respiratory movements, simultaneously with 
respiratory flow. The latest version of the ResMed 
Autoset® offers such a possibility, with a graphic re-
p o r t  o f  r e - 
spiratory effort, but has not been studied to our 
knowledge in a group of older patients.
When using nocturnal pulse-oximetry, it is impor-
tant to know whether the subject studied slept or not, 
and during which parts of the recording; Ancoli-Israël 
et al. studied the use of a wrist-activity monitor, and 
showed that it had a sensitivity of 87% and a spe-
cificity of 90% in differentiating sleep from wakeful-
ness (74). Another option to be explored is the use 
of continuous video recording, synchronized with the 
timer of the oximeter.
An interesting technique for detecting SDB in 
older subjects is the static charge-sensitive bed 
(SCSB), used by Erkinjuntti et al. (69) in patients with 
AD and MID. The SCSB consists of a thin mattress, 
sensitive to respiratory and body movements; record-
ing does not require any electrodes or cables con-
nected to the patient, and thus a more physiological 
sleep situation is achieved; coupling with pulse-oxi-
metry allows the distinction between OSA and peri-
odic breathing (CSB) (75). In a comparative study of 
77 patients studied simultaneously by polysomnogra-
phy and SCSB coupled with oximetry, Se was 100% 
and Sp was 67% for the detection of OSA (76).
CONCLUSIONS
Sleep disordered breathing occurs with increasing 
frequency in elderly subjects, either as predominant-
ly central apnea (i.e., Cheyne-Stokes or periodic 
breathing), or obstructive sleep apnea. Both entities 
cause important changes in the quality of sleep, with 
a markedly increased number of arousals and chang-
es in sleep stages, and a decrease in slow-wave sleep 
– the restorative component of sleep. The clinical 
symptoms may be subtle, but in non-demented sub-
jects SDB is associated with an increase in daytime 
sleepiness, and a variable intensity of neuropsycho-
logical dysfunction. In patients with dementia (Alzhe-
imer’s disease or multi-infarct disease), SDB probably 
occurs even more frequently, and may have a nega-
tive impact on cognitive performances. 
The finding of SDB is associated with a poorer 
prognosis in older patients; this is clearly documented 
in patients with cerebrovascular disease or severe 
heart failure. Because OSA and CSB are potentially 
reversible disorders, SDB should be considered in the 
differential diagnosis of “reversible dementias”, in-
creased daytime sleepiness, or unexplained right-
sided heart failure in the elderly.
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